Avantor (NYSE:AVTR) Reaches New 52-Week Low – Should You Sell?

Avantor, Inc. (NYSE:AVTR)’s stock price reached a new 52-week low during mid-day trading on Saturday . The stock traded as low as $19.08 and last traded at $19.15, with a volume of 14256681 shares trading hands. The stock had previously closed at $21.70.

Analyst Ratings Changes

AVTR has been the topic of several analyst reports. Raymond James cut their target price on Avantor from $29.00 to $26.00 and set an “outperform” rating on the stock in a research report on Tuesday, January 21st. Wells Fargo & Company cut their price objective on shares of Avantor from $30.00 to $28.00 and set an “overweight” rating on the stock in a research report on Monday, October 28th. Robert W. Baird lowered their target price on shares of Avantor from $27.00 to $26.00 and set an “outperform” rating for the company in a report on Monday, October 28th. Barclays upped their price target on shares of Avantor from $25.00 to $26.00 and gave the company an “overweight” rating in a report on Monday, February 3rd. Finally, UBS Group reissued a “neutral” rating and issued a $25.00 price objective (down from $29.00) on shares of Avantor in a research report on Friday, January 17th. Three investment analysts have rated the stock with a hold rating and ten have assigned a buy rating to the stock. According to data from MarketBeat.com, Avantor currently has an average rating of “Moderate Buy” and a consensus price target of $27.46.

Avantor Stock Down 11.8 %

The stock has a market cap of $13.03 billion, a P/E ratio of 41.63, a P/E/G ratio of 3.97 and a beta of 1.28. The company’s 50 day moving average price is $21.76 and its two-hundred day moving average price is $23.46. The company has a quick ratio of 1.06, a current ratio of 1.54 and a debt-to-equity ratio of 0.84.

Avantor (NYSE:AVTR) last issued its earnings results on Wednesday, February 12th. The company reported $0.27 earnings per share for the quarter, topping the consensus estimate of $0.26 by $0.01. Avantor had a return on equity of 12.24% and a net margin of 4.54%. During the same period in the previous year, the business posted $0.22 earnings per share. As a group, research analysts expect that Avantor, Inc. will post 0.98 earnings per share for the current year.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. MassMutual Private Wealth & Trust FSB lifted its position in shares of Avantor by 99.5% in the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 1,253 shares of the company’s stock worth $26,000 after purchasing an additional 625 shares during the period. Smartleaf Asset Management LLC lifted its holdings in Avantor by 106.3% during the fourth quarter. Smartleaf Asset Management LLC now owns 1,611 shares of the company’s stock worth $34,000 after buying an additional 830 shares during the period. UMB Bank n.a. bought a new stake in Avantor during the 3rd quarter valued at $49,000. Global Retirement Partners LLC increased its holdings in shares of Avantor by 76.7% in the 4th quarter. Global Retirement Partners LLC now owns 2,459 shares of the company’s stock valued at $52,000 after acquiring an additional 1,067 shares during the period. Finally, Nisa Investment Advisors LLC raised its position in shares of Avantor by 69.6% in the 3rd quarter. Nisa Investment Advisors LLC now owns 2,035 shares of the company’s stock worth $53,000 after acquiring an additional 835 shares in the last quarter. 95.08% of the stock is currently owned by institutional investors.

About Avantor

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.